Search
for
Sort by
Research 211–240 of 1000+
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- JAK inhibitor deuruxolitinib shows encouraging hair re-growth in alopecia areata
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Under Development JAK Inhibitors for Dermatologic Diseases
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors